Cargando…

1153. ESBL Producing E. coli Urinary Tract Infections in Children: Is Carbapenem Always Necessary?

BACKGROUND: Urinary tract infections (UTI) are common in children with a prevalence of 5% in infants. UTI are the main reason for beginning antibiotics in children’s hospitals and E. coli is approximate 80% of urinary pathogens. Extended-spectrum beta-lactamases (ESBL) producing E. coli are a common...

Descripción completa

Detalles Bibliográficos
Autores principales:	del Carmen, Ruiz Cabrales Diva, Oviedo, Gabriel Ivan Narvaez, Londono-Ruiz, Juan Pablo, Tobar, Ivan Felipe Gutiérrez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644781/ http://dx.doi.org/10.1093/ofid/ofab466.1346

Ejemplares similares

Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model
por: Neville, Lewis F., et al.
Publicado: (2022)

Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)
por: Branton, Alexander C, et al.
Publicado: (2023)

TOTAL OMENTECTOMY IN GASTRIC CANCER SURGERY: IS IT ALWAYS NECESSARY?
por: BARCHI, Leandro Cardoso, et al.
Publicado: (2019)

1673. Time to positivity of blood cultures in a pediatric hospital: more tools to reconsider empirical treatment in suspected infections.
por: Andrade-Fernandez, Joam C, et al.
Publicado: (2023)

1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI)
por: Branton, Alexander C, et al.
Publicado: (2021)

Detection of ESBL in E.coli and K. pneumoniae isolated from urinary tract infection
por: Metri, B. C., et al.
Publicado: (2012)

1153. National Trend of Urinary Catheter Device Utilization by Hospital Type, National Healthcare Safety Network (2015–2019)
por: Soe, Minn M
Publicado: (2019)

Detection of ESBL- and AmpC-producing E. coli isolates from urinary tract infections
por: Shayan, Sara, et al.
Publicado: (2015)

APC ain't always necessary for axons
por: Williams, Ruth
Publicado: (2008)

1153 Epidemiology and Trend in hepatitis A hospitalizations in the United States, 2002 – 2011
por: Collier, Melissa, et al.
Publicado: (2014)

First publication of endemic channels as part of a pediatric Antimicrobial Stewardship Program: when to turn on the alarms? Recommendations of a pediatric ASP program
por: Londoño-Ruiz, Juan Pablo, et al.
Publicado: (2023)

qnr Prevalence in Extended Spectrum Beta-lactamases (ESBLs) and None-ESBLs Producing Escherichia coli Isolated from Urinary Tract Infections in Central of Iran
por: Pakzad, Iraj, et al.
Publicado: (2011)

Monitoring fluoroquinolone resistance among ESBL-positive and ESBL-negative Escherichia coli strains isolated from urinary tract infections: An alert for empirical treatment
por: Araújo, Max Roberto Batista, et al.
Publicado: (2023)

ESBL-Producing and Non-ESBL-Producing Escherichia coli Isolates from Urinary Tract Differ in Clonal Distribution, Virulence Gene Content and Phylogenetic Group
por: Fang, Yewei, et al.
Publicado: (2023)

Carbapenem-Sparing Strategies for ESBL Producers: When and How
por: Karaiskos, Ilias, et al.
Publicado: (2020)

MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2021)

Pediatric Febrile Urinary Tract Infection Caused by ESBL Producing Enterobacteriaceae Species
por: Agegnehu, Asnakech, et al.
Publicado: (2020)

“Population structure of drug-susceptible,—resistant and ESBL-producing Escherichia coli from community-acquired urinary tract”
por: Hertz, Frederik Boëtius, et al.
Publicado: (2016)

The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
por: Alyamani, Essam J., et al.
Publicado: (2017)

Prevalence of ESBL and AmpC genes in E. coli isolates from urinary tract infections in the north of Iran
por: Sadeghi, M., et al.
Publicado: (2021)

Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
por: Fukuchi, Takahiko, et al.
Publicado: (2016)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

1657. Evaluating the Effectiveness of Biofire® FilmArray® BCID2 Sepsis Panel in Pediatric Antibiotic Stewardship Program: Less time and more control
por: Londono-Ruiz, Juan Pablo, et al.
Publicado: (2023)

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Large Multinodular Toxic Goiter: Is Surgery Always Necessary?
por: Negro, Roberto, et al.
Publicado: (2016)

Mesenchymal Hamartoma of the Liver: Complete Excision Always Necessary
por: Koganti, Suman B., et al.
Publicado: (2017)

Corrigendum: MIS-C Treatment: Is IVIG Always Necessary?
por: Licciardi, Francesco, et al.
Publicado: (2022)

Carbapenem is not always the best choice in the treatment of septic shock
por: Wang, Lu, et al.
Publicado: (2023)

Extended spectrum beta-lactamase (ESBL) strains of E. coli as a cause of urinary tract infections in hospitalized patients
por: Gerasimovska, V, et al.
Publicado: (2015)

ESBL Production Among E. coli and Klebsiella spp. Causing Urinary Tract Infection: A Hospital Based Study
por: Shakya, Pooja, et al.
Publicado: (2017)

P01 Urinary tract infections caused by ESBL-producing Escherichia coli in outpatients from Sarajevo, Bosnia and Herzegovina
por: Keser, Sejla Kotoric, et al.
Publicado: (2022)

2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018)

A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells
por: Liu, Shiyang, et al.
Publicado: (2016)

Diarrhoea and preadmission antibiotic exposure in COVID-19: a retrospective cohort study of 1153 hospitalised patients
por: Mateen, Bilal Akhter, et al.
Publicado: (2021)

1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019)

Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)–producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?
por: Stone, Tyler J., et al.
Publicado: (2023)

Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT—UTI)
por: Stefanos, Sylvia S, et al.
Publicado: (2023)

Detection of ctx-M gene in ESBL-producing E. coli strains isolated from urinary tract infection in Semnan, Iran
por: Tabar, Mahbobeh Mohammad, et al.
Publicado: (2016)

2422. Efficacy of Cefoxitin for the Treatment of Urinary Tract Infection (UTI) Due to ESBL-Producing E. coli and K. pneumoniae Isolates
por: Senard, Olivia, et al.
Publicado: (2018)

Erratum to: Population structure of Drug-Susceptible,—Resistant and ESBL-producing Escherichia coli from community-acquired urinary tract infections
por: Hertz, Frederik Boëtius, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dnffkenlrlsf3d2hd46b6ngcr8